Skip to main content
Premium Trial:

Request an Annual Quote

Gerald Vovis, Krishnan Nandabalan, Kevin Rakin, Andy Brimer

Premium

Genaissance Pharmaceuticals of New Haven, Conn., has promoted Gerald Vovis, from senior vice president, genomics, to CTO. Krishnan Nandabalan has been promoted from executive director, technology systems, to vice president, product development. Kevin Rakin, executive vice president and CFO, was also named president of the company.

As CTO, Vovis will oversee the expansion of the HAP Factory genomics center as well as the industrialization of the company’s HAPtyping facility, which determines which HAP Markers are present in patients’ DNA from clinical samples.

Nandabalan will direct the commercialization of Genaissance’s technologies and will be responsible for developing contacts with genomics and informatics professionals within prospective pharmaceutical partners.

Software company Intacta Technologies of Atlanta has assigned Andy Brimer with the task of heading a new bioinformatics division. As chief architect of the project, Brimer will also be responsible for deploying IBM’s WebSphere technology and Intacta.Code as a system for managing and sharing genomic data. Intacta is developing a system to distribute, select, and analyze data across different computing platforms.

Brimer, who has been a consultant at Intacta for the past eight months, is helping to map out bioinformatics products the company should develop, which may include a bioinformatics Web portal and laboratory information management systems. Eventually, Intacta may spin out the division. Brimer joined Intacta from kforce Consulting, an e-business development and integration company based in Tampa.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.